INTRODUCTION
Although the aetiology of Crohn's disease remains an enigma, it is now generally accepted that Crohn's disease results, in part or in whole, from an abnormal or dysregulated immune response to specific and/or commensal bacteria arising from the intestinal lumen in susceptible individuals (Haag & Siegmund, 2014) . As a result, there has been a great deal of attention devoted to the examination of the composition and function of the intestinal microbial populations known as the microbiota. Although the bacterial populations in downstream faecal material and adherent to mucosal surfaces have been found to be out of normal balance (dysbiotic) in Crohn's disease as compared to normal controls (Manichanh et al., 2012) , data accumulated to date have not elucidated the causative factors or aetiologic mechanisms of the disease. It remains unclear whether the dysbiosis is related to the cause of the disease or simply an effect of the disease unrelated to initial causality.
The intestinal microbiota is not constant throughout the gastrointestinal tract and studies in humans (Hayashi et al., 2005) and animals (Larsson et al., 2012) have shown significant differences in the composition of microbial populations along the intestinal tract. The microbial populations of the terminal ileum are not the same or comparable to those found in the colon any more than the microbiota of the mouth (He et al., 2015) can be compared to that of the anus or in faeces (Sha et al., 2013) . As downstream faecal material is only loosely reflected in the intestinal mucosa (Gevers et al., 2014) , the intestinal submucosal microbiome appears to be only loosely reflected in the mucosa (Chiodini et al., 2015) .
We hypothesized that, since Crohn's disease was a transmural disease, the examination of deep submucosal tissues and the bacterial populations directly associated with the inflammatory disease process would provide a unique insight into the microbiota capable of transgressing the intestinal barrier and be more representative of the causes and agents of the disease than bacteria merely adherent to mucosal surfaces or found in downstream faecal material. It was further hypothesized that bacteria associated with the submucosal tissues would be less diverse than those found on the mucosal surfaces and in faecal material. This hypothesis might differentiate between causative agents of disease and commensal side effects of intestinal inflammation.
In support of these hypotheses, we chose to examine bacterial populations within submucosal tissues rather than bacteria on mucosal surfaces as in other studies of the microbiota in Crohn's disease. Unlike ulcerative colitis or coeliac disease, which are predominately mucosal diseases, Crohn's disease is a transmural disease with involvement of the submucosa, the muscularis propria, the subserosa and mesenteric fat and can affect the entire gastrointestinal tract (Chiodini, 1989) . As such, disease is manifested predominately below the mucosal surface. Although the mucosal microbiota likely contributes to the clinical manifestations and aetiopathogenesis of the disease, examining the superficial bacterial populations on the mucosa may be akin to the examination of bacteria on the surface of an abscess as opposed to the bacteria within the abscess. Thus, our efforts have focused on the bacterial populations deep within the intestinal submucosa and inflammatory process in Crohn's disease.
The dysbiosis in Crohn's disease has been well documented and described in relation to presumed (Aine et al., 2014) normal controls (Gevers et al., 2014; Haberman et al., 2014) and likely contributes to the clinical manifestations of disease as well as being an important component in understanding overall disease pathogenesis. However, dysbiosis is a common manifestation in a variety of gastrointestinal disturbances, including obesity (Cani & Delzenne, 2009 ), coeliac disease (De Palma et al., 2010) , irritable bowel disease (Cremon et al., 2010) , colorectal cancer (Pagnini et al., 2011 ), diet (Turnbaugh et al., 2009 and cigarette smoking (Biedermann et al., 2014) to name just a few; it is unclear if the dysbiosis in Crohn's disease is a primary or secondary disease event. There is no information available on the differences in the microbiota between Crohn's disease and other intestinal disbiotic conditions. Whilst comparing the intestinal bacterial populations in Crohn's disease to that observed in alleged (Aine et al., 2014) normal intestinal tissues provides generalized information on dysbiosis, it provides only limited data specifically associated with Crohn's disease. Comparing the dysbiotic microbiota in Crohn's disease to other diseases manifesting a dysbiotic intestinal microflora may uniquely allow the identification of bacterial populations or species that are specifically associated with Crohn's disease and less influenced by the mucosal dysbiosis and anatomical changes resulting from inflammation. To address these issues, we selected non-normal intestinal tissues from other diseases known to have dysbiotic intestinal microflora as our comparison and control group (Guyot & Barrett, 2001; Castro, 2007) .
These innovative approaches, examining bacteria deep within the diseased submucosal tissues and comparing the microbiota in Crohn's disease to the microbiota in other dysbiotic intestinal diseases, may provide insight into bacteria specifically associated with the inflammatory process and aetiopathogenesis of Crohn's disease.
We previously reported the existence of a distinct submucosal microbiota within the diseased ileal tissues of patients with advanced Crohn's disease (Chiodini et al., 2015) . Within the centre of the lesion, a variety of organisms of the Phylum Firmicutes were found to be increased in the submucosa including Ruminococcus spp., Oscillospira spp., Pseudobutyrivibrio spp. and Tumebacillus spp. There were also increases in Proteobacteria including bacteria of the genera Parasutterella spp. and Methylobacterium spp. Unidentified organisms of the Order Desulfovibrionales were detected within the submucosal tissues of most Crohn's disease patients but absent in the control group (Chiodini et al., 2015) . Examination of the microbes within the submucosa and directly associated with the inflammatory process limited the number and diversity of bacterial agents as possible causative or augmentative agents of disease.
Recognizing that several bacterial diseases are characterized by aetiologic agents found predominately or exclusively within the advancing disease margin (the demarcation between healthy and diseased tissues) and at very low prevalence (Silva et al., 2015) , we performed deep Illumina MiSeq sequencing targeting the V1-3 variable region of the 16S rRNA gene for the determination of microbiota within submucosal tissues of the advancing disease margin in Crohn's disease. Our data suggest that the advancing disease margin may be the primary site of bacterial translocation across the mucosal barrier, with 13 bacterial families representing 16 different genera crossing the mucosal barrier.
METHODS
Patient populations. This study was approved by the institutional review boards of the University of Louisville, Texas Tech University Health Sciences Center, and the Institutional review board of Billings (St Vincent Healthcare and Montana State University-Billings). Informed consent was obtained from all patients prior to the collection of any specimens and/or data. Patients with ileal Crohn's disease and controls [representing terminal ileum from non-inflammatory bowel disease (non-IBD) populations] scheduled for surgical resection were recruited from the University of Louisville, Kentucky, and Texas Tech University Health Sciences Center, El Paso, and affiliated Hospitals (Table 1) . Detailed clinical history including gender, ethnicity, date of disease onset, past and current medications, use of probiotics and prebiotics, prior operations, family history, secondary disease sites, concurrent disease, use of pre-operative bowel preparation and other clinical parameters were collected at the time of informed consent. From each Crohn's disease patient, at least a one-half square inch (1.27 cm 2 ) full thickness section of the advancing disease margin was collected at time of surgery by an operating surgeon (Galandiuk et al., 2012) with extensive experience in inflammatory bowel disease surgery. The advancing disease margin was determined by the surgeon, after the resected specimen was opened immediately after resection along the anti-mesenteric border. As Crohn's disease is always most severe on the mesenteric margin, the anti-mesenteric margin was examined for the area where there was a discrete demarcation between normal and abnormal mucosa (mesenteric ulceration). In the absence of ulceration, thickening of the bowel/mesentery junction was used as a surrogate. Tissue samples were immediately frozen after collection. If the disease margin was not readily discernible during inspection at surgery, the patient was excluded from this study.
Tissue processing and DNA extraction. Methods employed for the processing of tissues, separation of mucosal and submucosal tissues and extraction of DNA have been described previously in detail (Chiodini et al., 2015) . Briefly, after the mucosal and submucosal layers were excised and separated followed by several washes in sterile water and chemical digestion, DNA was extracted from mucosal digests and submucosal tissue using in part the MoBio PowerMax Soil DNA Isolation Kit employing 100 µM molecular biology grade (MBG) Zirconium beads, digestion with proteinase K and the use of a high-energy cell disrupter (Chiodini et al., 2015) .
16S rRNA gene sequencing on the Illumina MiSeq platform.
The 16S universal eubacterial primers 27Fmod and 519Rmod were utilized to evaluate the microbial ecology of samples on the Illumina MiSeq platform with methods based upon the bTEFAP ® process as previously described (Chiodini et al., 2015) . Briefly, a single-step 30 cycle PCR using HotStarTaq Plus Master Mix Kit (Qiagen) was used under the following conditions: 94 C for 3 min, followed by 28 cycles of 94 C for 30 s, 53 C for 40 s and 72 C for 1 min, after which a final elongation step at 72 C for 5 min was performed. Multiple samples (single amplicons) were pooled together in equal proportions based on their molecular weight and DNA concentrations. Pooled samples were purified using calibrated Ampure XP beads. The pooled and purified PCR products were used to prepare DNA libraries according to the Illumina TruSeq DNA library preparation protocol.
Sequencing was performed using the Illumina MiSeq sequencing platform following the manufacturer's guidelines. The Q25 sequence data derived from the sequencing process were processed using a standardized analysis pipeline (Chiodini et al., 2015) . In brief, sequences were joined, depleted of barcodes; sequences <150 bp were removed, and sequences with ambiguous base calls were removed. Sequences were denoised, operational taxonomic units (OTUs) were generated and chimeras were removed using UCHIME (Edgar et al., 2011) . OTUs were defined after removal of singleton sequences, clustering at 3 % divergence (97 % similarity) using UCLUST in standard default (Dowd et al., 2008; Edgar, 2010) . Final OTUs were taxonomically classified using BLASTn against a curated database derived from GreenGenes Version 13.5 (http://greengenes.lbl.gov/cgi-bin/nph-index.cgi), RDPII (http://rdp.cme.msu.edu) and NCBI (www.ncbi.nlm.nih.gov) databases (including non-bacterial sequences) and compiled into each taxonomic level by both 'counts' (actual number of sequences) and 'percentage' (relative proportion of sequences within each sample) files. Rarefying was not performed (McMurdie & Holmes, 2014) .
OTUs were assigned taxonomic classification based on the following taxonomic designation (Chiodini et al., 2015) : >97 % identity was classified at the species level; between 97 and 95 % identity was designated as an unclassified species; between 95 and 90 % identity was designated as an unclassified genus; between 90 and 85 % identity was designated as an unclassified family; between 85 and 80 % identity was designated as an unclassified order; between 80 and 77 % identity was designated as an unclassified phylum; and <77 % identity was designated as unclassified.
DNA and bacterial quantitation. In an attempt to compensate for the bias created by erroneously assuming a 1 : 1 ratio of rRNA genes across the entire bacterial community, the actual number of sequences from the raw fasta count files was divided by the average number of rrn operons (rRNA copies) at each taxonomic level based on the Ribosomal RNA Database (Lee et al., 2009; Chiodini et al., 2015) .
Monitoring contamination. DNA extraction and sequencing kits as well as all reagents used in the processing of tissues were monitored for inherent bacterial DNA contamination as previously described (Glassing et al., 2016) . Briefly, to monitor contamination from reagents used during the DNA extraction procedure, MBG water was processed through all lots of any used DNA extraction kit and the product (extraction blanks) was sequenced as mentioned above concurrent with tissue DNA samples. To monitor for inherent contamination of the sequencing procedure, MBG water was also sequenced concurrently with tissue DNA samples. Thus, all sequencing of samples were accompanied by concurrent sequencing of DNA extraction blanks and MBG water (Glassing et al., 2016) .
Statistical analysis. Statistical analysis was performed using a variety of computer packages including XLSTAT-Biomed, NCSS 2007, 'R' (http://www.r-project.org/) and NCSS 2010 (Chiodini et al., 2015) . The statistical analysis of alpha and beta diversity was performed from taxonomic classifications and phylogenetic based methods (Jost, 2006) , not dependent on OTU assignments using the Qiime pipeline (www.qiime. org) with standard scripts and default settings for taxa assignments (genus and higher), diversity estimates (OTUs, Chao1 index, phylogenetic distance index, Shannon index and Simpson index) and phylogeny-based analyses using UniFrac. Because most datasets do not meet the assumptions of normal distribution, the differences in the proportions of bacterial taxa (defined as percentage of total sequences) between mucosal and submucosal groups were determined using non-parametric Kruskal-Wallis. For comparisons involving two or more groups, Kruskal-Wallis and Mann-Whitney post-test were applied (nonparametric data) or ANOVA with Tukey-Kramer post hoc analysis (parametric data). Comparisons between two groups were performed using Mann-Whitney and/or the paired Student t-test. Significance reported for any analysis was defined as P<0.05, corrected for multiple testing using ANOVA with Tukey's HSD (honestly significant difference) post hoc analysis.
RESULTS

Patient populations
Tissues from the terminal ileum were obtained from 20 patients with Crohn's disease and from 15 non-IBD controls. Of the 20 patients with Crohn's disease, an advancing disease margin could not be clearly defined in five patients and these patients were excluded from further analysis. All of these excluded patients had received anti-TNF treatment within 6 months of surgery. Of the remaining 15 patients with Crohn's disease, there were nine females and six males with a mean age of 42 years (range: 24-66 years). Thirteen patients were Caucasian and two were African American. Only three patients had received antibiotics, whilst six had received anti-TNF treatment (either infliximab or adalimumab) within 6 months of surgery. Disease duration ranged from 1 to 34 years (mean 15 years) and eight patients (53 %) had a previous small bowel resection. Four patients had a relative with Crohn's disease (Table 1 ).
The non-IBD control population consisted of 11 female and 4 male patients undergoing ileocolic resection for a variety of reasons unrelated to IBD (Table 1 ). An effort was made to obtain a diverse control population. Nine of the control patients were Caucasian, five were Hispanic and one was African American. The mean age of this population was 57 years (range: 32-88 years) and four patients had received antibiotics within 6 months prior to surgery. There was no statistically significant correlation between the detected microbiota and any clinical parameter, likely the result of cohort size and population diversity (with respect to ethnicity, geographic location, medical condition, etc.).
Overall sequencing results
A total of 60 DNA samples were processed and examined (superjacent mucosa and subjacent submucosa from each of the 30 patients). From these samples, 2 688 864 sequences were generated of which 2 629 368 (97.8 %) aligned to the Kingdom Bacteria. The number of sequences generated per sample averaged 46 337. These sequences clustered into 7321 unique sequences or OTUs at 3 % divergence (97 % homology), allowing for identification of 15 bacterial phyla, 12 classes, 59 orders, 122 families, 305 genera and 798 tentative species. The average number of bacterial species identified per patient was 128 (range: 32-246) with an average of 72 species detected in greater than 50 % of the study population.
As expected, the mucosa contained a greater number of detected bacterial genera as compared to the submucosa (291 vs 266; P=0.02). Within the mucosal tissues, there was an average of 94.5 genera per patient (range: 42-136) with 80 genera detected in >50 % of patients. In contrast, within the submucosa, the average number of genera was 80.8 (range: 50-137) with 63 genera identified in >50 % of the patients.
Mucosal microbiota at the advancing disease margin
The mucosal microbiota of the non-IBD control population examined in this study would be considered to be in imbalance (dysbiotic) in relation to what has been generally reported as normal (Robles Alonso & Guarner, 2013; Koboziev et al., 2014) . Despite this dysbiotic state, there were clear differences between the non-IBD and Crohn's disease populations, suggesting a mucosal microbiota profile unique to Crohn's disease. However, although a unique dysbiotic mucosal microbiota was suggested by the data, many of the conventional dysbiotic characteristics in Crohn's disease were not unique when compared to other intestinal disorders.
Increased organisms of the Phyla Proteobacteria are considered to be a prominent trait of Crohn's disease (Mukhopadhya et al., 2012) , and these organisms were increased within the mucosal layer at the advancing disease margin above that generally considered normal. However, the 17 % relative prevalence in Crohn's disease, although increased, was statistically less than the 32 % prevalence observed within the mucosa of non-IBD controls (Fig. 1,  MM vs cNM) . The high relative prevalence of Proteobacteria in the non-IBD controls suggests that the increased prevalence of Proteobacteria in Crohn's disease is not specifically associated with Crohn's disease but is a common occurrence in gastrointestinal disease and inflammation (Winter & Baumler, 2014a, b) . The decreased relative prevalence of Proteobacteria as compared to non-IBD controls was likely due to the diminished prevalence of bacteria within the Alphaproteobacteria and Betaproteobacteria classes and increased members of the Class Bacteroidia in Crohn's disease as compared to non-IBD controls. Differences in the mucosal microbiota between non-IBD controls and the advancing disease margin in Crohn's disease were associated with 9 bacterial families and 10 genera (Fig. 2 , Table 2 ).
The dysbiotic bacterial community of the mucosa at the advancing disease margin was largely associated with a relative increase in bacteria of the Families Bacteroidaceae, Coriobacteriaceae and Enterobacteriaceae and decreased relative prevalence of Burkholderiaceae, Comamonadaceae, Oxalobacteraceae, Prevotellaceae, Propionibacteriaceae and Pseudomonadaceae as compared to the non-IBD controls. The increase in bacteria of the Family Enterobacteriaceae was not associated with the Genus Escherichia or otherwise related to adherent invasive Escherichia coli (AIEC).
There was no significant difference in the biodiversity of the mucosal bacterial populations between Crohn's disease and the mucosal microbiota of other intestinal diseases examined. Contrary to previous findings comparing Crohn's disease to normal mucosa (Haberman et al., 2014) , we found there was increased species richness of the mucosal microbiota in Crohn's disease (mean 94 species) as compared to other intestinal diseases (mean 59 species) (P 0.001).
Submucosal microbiota at the advancing disease margin
There was no significant increase in bacteria within the submucosa of non-IBD controls at any taxonomic level when compared to the corresponding superjacent mucosa (Fig. 1, cNM vs cNS) . The absence of any detectable difference between the superjacent mucosa and subjacent submucosa in non-IBD controls suggests the absence of bacterial translocation and an intact functional mucosal barrier.
In contrast, in Crohn's disease, there was a statistically significant increase in 13 bacterial families and 16 bacterial genera within the submucosa at the advancing disease margin when compared to the corresponding superjacent mucosa (Fig. 1, MS organisms within the submucosa and this was the most prominent bacterial family within the submucosa. Bacteria of low relative prevalence but high fold increase within the subjacent submucosa included Sphingomonadaceae, Alicyclobacillaceae, Methylobacteriaceae and Prevotellaceae (Fig. 3a, Table 3 ). Bacterial genera corresponding to these Families were likewise increased (Fig. 3b) . Bacterial families and genera detected within the Crohn's disease submucosa represented a relative prevalence of 36 and 15 %, respectively, of all detected bacterial sequences.
The bacteria detected within the submucosa did not correspond to any specific bacterial classification but rather represented a group of diverse non-specific bacterial types encompassing the Phyla Proteobacteria, Bacteroidetes and Firmicutes. There were no identified organisms with any known predilection towards mucosal translocation, adherence or invasion. Organisms related to AIEC, reported to be elevated within the mucosal surfaces (Martinez-Medina & Garcia-Gil, 2014), were not increased within submucosal tissues and failed to display any inclination towards tissue invasion and survival.
As would be expected with the limited types of bacteria present, there was reduced biodiversity (P=0.005) and species richness (P=0.02) within the subjacent submucosa as compared to the superjacent mucosa.
Changes in the microbiota from diseased to advancing disease margin
Having established the microbiota profile and community at the advancing disease margin, we sought to compare how the microbiota changed in relation to that previously described at the centre of the disease lesion (Chiodini et al., 2015) .
At all taxonomic levels, from Phyla to Genus, there was a statistically significant decrease in certain bacterial groups between the centre of the lesion and the advancing disease margin (Fig. 1, DM vs MM) . Except for organisms of the Family Campylobacteraceae, Genus Campylobacter, which were increased twofold at the advancing disease margin, Genera represented by the Families Alicyclobacillaceae, Bacillaceae, Brucellaceae, Coriobacteriaceae, Rikenellaceae and Xanthomonadaceae were all reduced in the mucosa of the advancing disease margin (MM) as compared to the mucosa of the centre of the Crohn's disease lesion (DM) (Fig. 4a) . Conversely, these Families were increased at the disease centre as compared to the disease margin.
Contrary to the findings at the mucosal level where there was a general decrease in the relative prevalence of most organisms in the mucosa at the centre of the disease lesion (DM) as opposed to the mucosa at the advancing disease margin (MM), in the submucosa (MS), there was an increase in the relative frequency of bacteria of the Families Gemellaceae (P=0.003), Peptostreptococcaceae (P=0.04), Prevotellaceae (P=0.02) and Streptococcaceae (P=0.03) as compared to the centre of the disease (DS). Only organisms of the Family Methylobacteriaceae were reduced (P=0.04) within the submucosa of the advancing disease margin in comparison to the centre of the disease (Fig. 1 , DS vs MS and Fig. 4b ).
Comparing the submucosal microbiota of the advancing disease margin to that of the centre of the disease lesion based on increased submucosal prevalence (translocation) at the examination site (MM vs MS and DM vs DS; Fig. 1) revealed a far greater level of bacterial penetration at the advancing disease margin than at the disease centre (Table 4) . Four of the five bacterial families increased in the submucosa at the disease centre (Alicyclobacillaceae, Methylobacteriaceae, Prevotellaceae and Ruminococcaceae) were also statistically increased within the submucosa of the advancing disease margin. The additional nine bacterial families identified within the advancing disease margin were not detected within the submucosa at the disease centre.
Organisms detected within the submucosal tissues at the advancing disease margin did not comprise any specific bacterial taxa or classification but represented all the major bacterial phyla commonly found within the gastrointestinal tract, namely bacteria of the Phyla Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes. Of the 16 bacterial Fig. 2 . Major differences in the mucosal microbiota between the advancing disease margin (MM) in Crohn's disease (CD) and the mucosa of non-IBD controls (nIBD) included 9 bacterial families (a) and 10 bacterial genera (b). Although both mucosal tissues are dysbiotic, the differences between Crohn's disease and non-IBD controls suggest a dysbiotic profile unique to Crohn's disease. Heat map (c) of the major differences in the mucosal microbiota between Crohn's disease and non-IBD controls.
genera elevated within the submucosa at the advancing disease margin, none are known to be specifically associated with gastrointestinal disease or having a predilection to cross the mucosal barrier.
DISCUSSION
We chose to limit our examination to ileal Crohn's disease in an attempt to reduce variability in disease phenotype and because ileal disease is most likely to involve host-microbial interactions in disease pathogenesis. A proportion of Caucasian Crohn's disease patients of European descent have genetic polymorphisms associated with the recognition of bacterial antigens and in immunologic components associated with the ability to kill intracellular bacteria. These polymorphisms, specifically the NOD2/CARD15 and the autophagyassociated ATG16L1 and IRGM genes (Liu & Anderson, 2014) , suggest genetic susceptibility linked to commensal and/ or certain pathogenic bacteria. Furthermore, a variety of murine and patient studies suggest that the terminal ileum plays a key role as a sensor of bacterial colonization and tolerance and is likely the primary inductive site for immune pathogenesis in Crohn's disease (Gullberg & Soderholm, 2006; Jung et al., 2010; Larsson et al., 2012) .
Thus, the diseased submucosal tissue in ileal Crohn's disease represents a logical area of investigation to determine bacterial populations in direct contact with the host's immune system and directly associated with transmural inflammatory lesions. Likewise, comparing bacterial populations in Crohn's disease to those found in other dysbiotic intestinal conditions is a logical approach to determining uniqueness and possible aetiopathogenic relationships of Crohn's disease-associated bacterial populations as opposed to differences from alleged normal tissues. Fig. 3 . Fold increase in bacterial families (a) and genera (b) within the subjacent submucosa of the advancing disease margin (MS) in Crohn's disease as compared to the superjacent mucosal layer (MM). The increase in these 13 bacterial families and 16 genera within the submucosa suggests an increased ability of these bacteria to penetrate and translocate across the mucosal barrier. The ability to separate mucosal and submucosal tissues without cross-contamination is a challenging procedure. In our data analyses, we assume that submucosal tissues are contaminated with small amounts of bacteria from the mucosa in equal relative concentration and prevalence and, since comparing superjacent to subjacent tissues, relative abundances from cross-contamination should cancel each other out. Although the organisms detected in the subjacent submucosa were predominately the same as those detected in the superjacent mucosa, there was no significant difference in relative prevalence. This would be expected assuming the submucosa is a sterile environment. In contrast, in Crohn's disease, there was always increased prevalence of certain bacterial taxa as compared to the superjacent mucosa. Assuming contamination of the submucosa with bacteria from the mucosal surface, such cross-contamination would occur at an equal relative concentration of all bacteria in an alleged sterile environment (the submucosa)
such that any increased bacterial prevalence could only occur if an initial bacterial population existed within the submucosa. Thus, we believe that the increased prevalence of certain bacterial types within the submucosa is real and cannot be attributed to mucosal contamination.
However, our assumption of mucosal contamination accounting for the presence of bacterial DNA within the submucosa may be erroneous. Exogenous DNA from the gastrointestinal tract is known to occur in the circulation and in other body fluids and tissues in a presumed cell-free state (Bertheau et al., 2009; Spisak et al., 2013) . In our own studies of the microbiota within peripheral blood, we have found bacterial rRNA genes corresponding and reflecting populations present within mucosal and submucosal tissues (unpublished data). Since peripheral blood cannot be crosscontaminated from mucosal tissues, it may be erroneous to assume that the variety of bacterial DNA detected within submucosal intestinal tissues resulted from mucosal crosscontamination. Furthermore, the widespread contamination of MBG reagents with common intestinal bacteria (Glassing et al., 2016) may also contribute to bacterial DNA detection within tissues.
Our results for the microbiota of the mucosa at the advancing disease margin (Fig. 1, MM ) in Crohn's disease were found to be significantly different from those previously reported for normal mucosal tissue and superficial colonoscopy-guided mucosal biopsies (Robles Alonso & Guarner, 2013; Koboziev et al., 2014) . These differences likely result from our comparison of Crohn's disease to other dysbiotic diseases and conditions affecting the gastrointestinal tract in anticipation that the results would be more indicative of microbial population profiles unique to Crohn's disease and not simply reflective of intestinal inflammation. As a result, our data contradict some of the basic concepts regarding Proteobacteria, AIEC, biodiversity and richness, as well as their distinctiveness to inflammatory bowel disease.
The microbiota in Crohn's disease is generally associated with increased organisms of the Phylum Proteobacteria on mucosal surfaces and in downstream faecal material . Our results suggest that although elevated, the increased prevalence of Proteobacteria in Crohn's disease is not significantly more than in other intestinal disturbances and diseases. These findings support the notion that increased prevalence of Proteobacteria is associated with inflammation in general (Winter & Baumler, 2014a, b) and is not specific to Crohn's disease. Likewise, although Crohn's disease is associated with an increased prevalence of AIEC (Martinez-Medina & Garcia-Gil, 2014), there does not appear to be a generalized increase in E. coli within mucosal surfaces and E. coli does not appear to have an increased predilection to invade submucosal tissues. Although AIEC do not have any unique genetic traits and cannot be differentiated from 'normal' E. coli by rRNA gene sequencing, the lack of an increased prevalence of E. coli in general within the mucosa or submucosa as compared to other intestinal disturbances supports the notion that inflammation drives the phenotypic expression of AIEC (Craven et al., 2012) and that the presence of AIEC may not be specific to Crohn's disease. In addition, although the faecal and mucosal microbiota in Crohn's disease has lower diversity and species richness as compared to normal flora (Wright et al., 2015) , our data comparing Crohn's disease to other intestinal diseases do not support this concept. In fact, our data suggest no significant difference in biodiversity and greater species richness in Crohn's disease as compared to other intestinal diseases. We also failed to find any significant difference in the prevalence of Faecalibacterium prausnitzii. Although a limited sample size, our data comparing the microbiota of Crohn's disease to other intestinal disorders rather than 'normal' contradict many of the current concepts regarding the microbiota in Crohn's disease as related to aetiopathogenesis.
The most notable feature of our findings on the mucosal layer at the advancing disease margin as opposed to the disease centre was the significant increase of bacteria of the Genus Campylobacter (Fig. 4a) . These organisms aligned predominately with Campylobacter concisus and Centruroides gracilis, both of which, particularly C. concisus, are capable of causing gastrointestinal disturbances and upsetting the mucosal barrier (Burgos-Portugal et al., 2014; Zhang, 2015) . These findings support the hypothesis that certain bacterial pathogens are predominately found within the ecological niche of the advancing disease margins and add some support for the involvement of Campylobacter spp. in Crohn's disease Zhang et al., 2014) . Although these organisms showed no predilection to penetrate the mucosal barrier or invade the submucosal tissues (there was no statistically significant increase in the subjacent submucosa as compared to the superjacent mucosa), these organisms could modulate intestinal epithelial barrier function (Nielsen et al., 2011; Awad et al., 2015) , thereby causing an influx of commensal organisms leading to a cascade of events eventually resulting in disease. Only four bacterial families detected within the submucosa of the centre of the disease lesion were also found to be increased within the submucosa of the advancing disease margin. These bacteria, except for Prevotellaceae, are members of the Phylum Firmicutes that are typically anaerobic (Class Clostridia) or facultative aerobes (Class Bacilli) and whose diversity is generally decreased in Crohn's disease. This group of organisms includes some notable pathogens (Mallozzi et al., 2010) and has a reputation for promiscuous plasmid exchange across species and genera. It remains to be determined if this group of organisms, shared within the submucosa of the advancing disease margin (the burning edge) and the centre of the disease lesion (scorched and burnt), is related to disease aetiology and pathogenesis or represents lingering taxa capable of surviving within the hostile microenvironment of the inflammatory response.
In contrast to our findings at the centre of the disease lesion, the submucosa of the advancing disease margin was found to be infiltrated with bacteria of 13 different families, almost threefold that of the disease centre, representing a significant increase in submucosal infiltration and colonization compared to that observed in the centre of disease. Although Proteobacteria and Firmicutes were the most prevalent Phyla within submucosal tissues, Actinobacteria and Bacteroidetes were also represented, as were a mixture of Gram-negative and Gram-positive anaerobic and facultative anaerobic bacteria. These findings suggest that the bacterial translocation observed in Crohn's disease at the advancing disease margin is not related to any specific type or class of bacteria but is represented by a pleomorphic mixture of bacteria, all of which presumably share the ability to penetrate and survive within host submucosal tissues. The observation that bacterial families detected within the Crohn's disease submucosa represented a relative prevalence of 36 % of all detected bacterial genomes supports the notion that the bacterial influx within the submucosa at the advancing disease margin is non-specific (O'Brien et al., 2014) .
Our data suggest that the primary site of bacterial translocation across the mucosal barrier in Crohn's disease occurs primarily at the margin between diseased and normal tissue, the 'advancing disease margin'. The heterogeneity of bacterial populations penetrating the mucosal barrier and colonizing the submucosal intestinal tissues and therefore contributing to the inflammatory processes suggests that bacterial translocation is secondary to a primary event leading to a breakdown of the mucosal barrier (Antoni et al., 2014) .
